Publikace
- Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed2017 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib2016 | 1. lékařská fakulta, Lékařská fakulta v Plzni, Přírodovědecká fakulta
- Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis2016 | 1. lékařská fakulta, Lékařská fakulta v Plzni, Fakulta tělesné výchovy a sportu
- G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab2016 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Prognostic Significance of Serum Tumor Markers in Patients with Advanced-stage NSCLC Treated with Pemetrexed-based Chemotherapy2016 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy2016 | Lékařská fakulta v Plzni
- High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib2015 | 1. lékařská fakulta, Lékařská fakulta v Plzni, Přírodovědecká fakulta
- Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation2015 | Lékařská fakulta v Plzni, Přírodovědecká fakulta
- Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiency2015 | 1. lékařská fakulta
- Efficacy of everolimus in second- and third-line therapy for metastatic renal cell carcinoma: A registry-based analysis2014 | 1. lékařská fakulta, Lékařská fakulta v Plzni, 2. lékařská fakulta
Loading network view...
